nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—Hormone ligand-binding receptors—TSHB—hypothyroidism	0.0884	0.3	CbGpPWpGaD
Degarelix—GNRHR—Hormone ligand-binding receptors—TSHR—hypothyroidism	0.0884	0.3	CbGpPWpGaD
Degarelix—GNRHR—gonad—hypothyroidism	0.0217	0.239	CbGeAlD
Degarelix—GNRHR—pituitary gland—hypothyroidism	0.0211	0.234	CbGeAlD
Degarelix—Acute coronary syndrome—Liothyronine—hypothyroidism	0.019	0.031	CcSEcCtD
Degarelix—Myocardial infarction—Liothyronine—hypothyroidism	0.0189	0.0308	CcSEcCtD
Degarelix—GNRHR—Peptide GPCRs—TSHR—hypothyroidism	0.0178	0.0605	CbGpPWpGaD
Degarelix—GNRHR—female gonad—hypothyroidism	0.0176	0.195	CbGeAlD
Degarelix—Abscess—Liotrix—hypothyroidism	0.0158	0.0256	CcSEcCtD
Degarelix—GNRHR—testis—hypothyroidism	0.0156	0.173	CbGeAlD
Degarelix—Arrhythmia—Liothyronine—hypothyroidism	0.0155	0.0252	CcSEcCtD
Degarelix—GNRHR—cerebellum—hypothyroidism	0.0144	0.159	CbGeAlD
Degarelix—Hypertension—Liothyronine—hypothyroidism	0.013	0.0212	CcSEcCtD
Degarelix—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0126	0.0205	CcSEcCtD
Degarelix—Cardiac failure—Levothyroxine—hypothyroidism	0.0126	0.0205	CcSEcCtD
Degarelix—Hypotension—Liothyronine—hypothyroidism	0.0115	0.0187	CcSEcCtD
Degarelix—Muscular weakness—Levothyroxine—hypothyroidism	0.0109	0.0177	CcSEcCtD
Degarelix—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0109	0.0177	CcSEcCtD
Degarelix—Swelling—Liotrix—hypothyroidism	0.0103	0.0167	CcSEcCtD
Degarelix—Body temperature increased—Liothyronine—hypothyroidism	0.00973	0.0158	CcSEcCtD
Degarelix—Weight decreased—Dextrothyroxine—hypothyroidism	0.00962	0.0157	CcSEcCtD
Degarelix—Weight decreased—Levothyroxine—hypothyroidism	0.00962	0.0157	CcSEcCtD
Degarelix—GNRHR—G alpha (q) signalling events—TRH—hypothyroidism	0.00953	0.0323	CbGpPWpGaD
Degarelix—Renal impairment—Liotrix—hypothyroidism	0.00951	0.0155	CcSEcCtD
Degarelix—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00935	0.0152	CcSEcCtD
Degarelix—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00935	0.0152	CcSEcCtD
Degarelix—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00929	0.0151	CcSEcCtD
Degarelix—Myocardial infarction—Levothyroxine—hypothyroidism	0.00929	0.0151	CcSEcCtD
Degarelix—Cardiac failure—Liotrix—hypothyroidism	0.00927	0.0151	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00852	0.0289	CbGpPWpGaD
Degarelix—Muscular weakness—Liotrix—hypothyroidism	0.00798	0.013	CcSEcCtD
Degarelix—Arrhythmia—Levothyroxine—hypothyroidism	0.0076	0.0124	CcSEcCtD
Degarelix—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0076	0.0124	CcSEcCtD
Degarelix—Alopecia—Levothyroxine—hypothyroidism	0.00752	0.0122	CcSEcCtD
Degarelix—Alopecia—Dextrothyroxine—hypothyroidism	0.00752	0.0122	CcSEcCtD
Degarelix—Weight decreased—Liotrix—hypothyroidism	0.00708	0.0115	CcSEcCtD
Degarelix—Acute coronary syndrome—Liotrix—hypothyroidism	0.00687	0.0112	CcSEcCtD
Degarelix—Renal failure—Liotrix—hypothyroidism	0.00685	0.0112	CcSEcCtD
Degarelix—Myocardial infarction—Liotrix—hypothyroidism	0.00684	0.0111	CcSEcCtD
Degarelix—Palpitations—Dextrothyroxine—hypothyroidism	0.00655	0.0107	CcSEcCtD
Degarelix—Palpitations—Levothyroxine—hypothyroidism	0.00655	0.0107	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00631	0.0214	CbGpPWpGaD
Degarelix—Arthralgia—Levothyroxine—hypothyroidism	0.00631	0.0103	CcSEcCtD
Degarelix—Arthralgia—Dextrothyroxine—hypothyroidism	0.00631	0.0103	CcSEcCtD
Degarelix—Hypoaesthesia—Liotrix—hypothyroidism	0.00623	0.0101	CcSEcCtD
Degarelix—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00585	0.00951	CcSEcCtD
Degarelix—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00585	0.00951	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00563	0.0191	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00563	0.0191	CbGpPWpGaD
Degarelix—Arrhythmia—Liotrix—hypothyroidism	0.00559	0.0091	CcSEcCtD
Degarelix—Alopecia—Liotrix—hypothyroidism	0.00553	0.009	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00551	0.00896	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00551	0.00896	CcSEcCtD
Degarelix—Insomnia—Dextrothyroxine—hypothyroidism	0.00547	0.0089	CcSEcCtD
Degarelix—Insomnia—Levothyroxine—hypothyroidism	0.00547	0.0089	CcSEcCtD
Degarelix—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00539	0.00877	CcSEcCtD
Degarelix—Dyspnoea—Levothyroxine—hypothyroidism	0.00539	0.00877	CcSEcCtD
Degarelix—Fatigue—Dextrothyroxine—hypothyroidism	0.00521	0.00848	CcSEcCtD
Degarelix—Fatigue—Levothyroxine—hypothyroidism	0.00521	0.00848	CcSEcCtD
Degarelix—Vision blurred—Liotrix—hypothyroidism	0.00514	0.00836	CcSEcCtD
Degarelix—GNRHR—G alpha (q) signalling events—AVP—hypothyroidism	0.00501	0.017	CbGpPWpGaD
Degarelix—Feeling abnormal—Levothyroxine—hypothyroidism	0.00498	0.00811	CcSEcCtD
Degarelix—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00498	0.00811	CcSEcCtD
Degarelix—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00494	0.00805	CcSEcCtD
Degarelix—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00494	0.00805	CcSEcCtD
Degarelix—Palpitations—Liotrix—hypothyroidism	0.00482	0.00784	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—TRH—hypothyroidism	0.00481	0.0163	CbGpPWpGaD
Degarelix—Urticaria—Levothyroxine—hypothyroidism	0.0048	0.00782	CcSEcCtD
Degarelix—Urticaria—Dextrothyroxine—hypothyroidism	0.0048	0.00782	CcSEcCtD
Degarelix—Body temperature increased—Levothyroxine—hypothyroidism	0.00478	0.00778	CcSEcCtD
Degarelix—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00478	0.00778	CcSEcCtD
Degarelix—Abdominal pain—Levothyroxine—hypothyroidism	0.00478	0.00778	CcSEcCtD
Degarelix—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00478	0.00778	CcSEcCtD
Degarelix—Hypertension—Liotrix—hypothyroidism	0.0047	0.00766	CcSEcCtD
Degarelix—Arthralgia—Liotrix—hypothyroidism	0.00464	0.00755	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00448	0.0152	CbGpPWpGaD
Degarelix—Anaphylactic shock—Liotrix—hypothyroidism	0.00445	0.00724	CcSEcCtD
Degarelix—Asthenia—Levothyroxine—hypothyroidism	0.00434	0.00706	CcSEcCtD
Degarelix—Asthenia—Dextrothyroxine—hypothyroidism	0.00434	0.00706	CcSEcCtD
Degarelix—Hyperhidrosis—Liotrix—hypothyroidism	0.0043	0.007	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—TSHB—hypothyroidism	0.00428	0.0145	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—TSHR—hypothyroidism	0.00428	0.0145	CbGpPWpGaD
Degarelix—Pruritus—Dextrothyroxine—hypothyroidism	0.00428	0.00696	CcSEcCtD
Degarelix—Pruritus—Levothyroxine—hypothyroidism	0.00428	0.00696	CcSEcCtD
Degarelix—Hypotension—Liotrix—hypothyroidism	0.00416	0.00676	CcSEcCtD
Degarelix—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00414	0.00673	CcSEcCtD
Degarelix—Diarrhoea—Levothyroxine—hypothyroidism	0.00414	0.00673	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00405	0.00659	CcSEcCtD
Degarelix—Insomnia—Liotrix—hypothyroidism	0.00402	0.00655	CcSEcCtD
Degarelix—Dyspnoea—Liotrix—hypothyroidism	0.00397	0.00645	CcSEcCtD
Degarelix—Decreased appetite—Liotrix—hypothyroidism	0.00387	0.00629	CcSEcCtD
Degarelix—Vomiting—Dextrothyroxine—hypothyroidism	0.00384	0.00626	CcSEcCtD
Degarelix—Vomiting—Levothyroxine—hypothyroidism	0.00384	0.00626	CcSEcCtD
Degarelix—Fatigue—Liotrix—hypothyroidism	0.00383	0.00624	CcSEcCtD
Degarelix—Rash—Dextrothyroxine—hypothyroidism	0.00381	0.0062	CcSEcCtD
Degarelix—Rash—Levothyroxine—hypothyroidism	0.00381	0.0062	CcSEcCtD
Degarelix—Dermatitis—Dextrothyroxine—hypothyroidism	0.00381	0.0062	CcSEcCtD
Degarelix—Dermatitis—Levothyroxine—hypothyroidism	0.00381	0.0062	CcSEcCtD
Degarelix—Constipation—Liotrix—hypothyroidism	0.0038	0.00619	CcSEcCtD
Degarelix—Headache—Dextrothyroxine—hypothyroidism	0.00379	0.00616	CcSEcCtD
Degarelix—Headache—Levothyroxine—hypothyroidism	0.00379	0.00616	CcSEcCtD
Degarelix—Feeling abnormal—Liotrix—hypothyroidism	0.00367	0.00596	CcSEcCtD
Degarelix—Gastrointestinal pain—Liotrix—hypothyroidism	0.00364	0.00592	CcSEcCtD
Degarelix—Nausea—Dextrothyroxine—hypothyroidism	0.00359	0.00584	CcSEcCtD
Degarelix—Nausea—Levothyroxine—hypothyroidism	0.00359	0.00584	CcSEcCtD
Degarelix—Urticaria—Liotrix—hypothyroidism	0.00353	0.00575	CcSEcCtD
Degarelix—Abdominal pain—Liotrix—hypothyroidism	0.00352	0.00572	CcSEcCtD
Degarelix—Body temperature increased—Liotrix—hypothyroidism	0.00352	0.00572	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00332	0.0112	CbGpPWpGaD
Degarelix—Hypersensitivity—Liotrix—hypothyroidism	0.00328	0.00533	CcSEcCtD
Degarelix—Asthenia—Liotrix—hypothyroidism	0.00319	0.00519	CcSEcCtD
Degarelix—Pruritus—Liotrix—hypothyroidism	0.00315	0.00512	CcSEcCtD
Degarelix—Diarrhoea—Liotrix—hypothyroidism	0.00304	0.00495	CcSEcCtD
Degarelix—Dizziness—Liotrix—hypothyroidism	0.00294	0.00479	CcSEcCtD
Degarelix—Vomiting—Liotrix—hypothyroidism	0.00283	0.0046	CcSEcCtD
Degarelix—Rash—Liotrix—hypothyroidism	0.0028	0.00456	CcSEcCtD
Degarelix—Dermatitis—Liotrix—hypothyroidism	0.0028	0.00456	CcSEcCtD
Degarelix—Headache—Liotrix—hypothyroidism	0.00279	0.00453	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—TRH—hypothyroidism	0.00272	0.00921	CbGpPWpGaD
Degarelix—Nausea—Liotrix—hypothyroidism	0.00264	0.0043	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—AVP—hypothyroidism	0.00252	0.00856	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—TRH—hypothyroidism	0.00247	0.00836	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—TSHB—hypothyroidism	0.00242	0.00821	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—TSHR—hypothyroidism	0.00242	0.00821	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.0022	0.00747	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—TSHB—hypothyroidism	0.0022	0.00745	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—TSHR—hypothyroidism	0.0022	0.00745	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CLTC—hypothyroidism	0.00169	0.00572	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—POMC—hypothyroidism	0.00168	0.00569	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—VAV3—hypothyroidism	0.00148	0.00502	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TRH—hypothyroidism	0.00146	0.00494	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AVP—hypothyroidism	0.00143	0.00484	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—VAV3—hypothyroidism	0.00134	0.00456	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TSHB—hypothyroidism	0.0013	0.0044	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TSHR—hypothyroidism	0.0013	0.0044	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AVP—hypothyroidism	0.0013	0.00439	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SH2B3—hypothyroidism	0.00116	0.00392	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—POMC—hypothyroidism	0.000948	0.00321	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—POMC—hypothyroidism	0.000861	0.00292	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRL—hypothyroidism	0.000859	0.00291	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—VAV3—hypothyroidism	0.000794	0.00269	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AVP—hypothyroidism	0.000765	0.00259	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—POMC—hypothyroidism	0.000509	0.00172	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1—hypothyroidism	0.000489	0.00166	CbGpPWpGaD
